Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. - sprookjes - yvandenbroek - TriplyDB

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37624523

about

Surgery combined with radio-chemotherapy for esophageal mucoepidermoid carcinoma: A case report.

P2860

Q55437120-B20EF673-76AE-4CD3-BD12-CA5920CB4958

P2860

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q37624523

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@en

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@nl

type

label

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@en

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@nl

prefLabel

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@en

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@nl

P1433

Q37624523-1D8DD819-7E04-4E4C-819E-8A250B09EC7E

P1476

Q37624523-47D0928B-0562-4D5F-82E8-B2E7569B0054

P2093

Q37624523-007D562F-7D9B-4538-AE1D-27E6B603F92B

Q37624523-489B46C1-1B6D-4951-9A54-E4075F00856B

Q37624523-57EA2737-1648-4721-86BC-1CA1C1069331

Q37624523-5FF33097-2FCD-443F-A3B0-21BB474EB51F

Q37624523-6E991D60-F264-4ED1-B0E8-CDB9CE0BB809

Q37624523-705A531A-E96A-4F10-9B37-2CEE3EBC5756

Q37624523-82AA8F72-3955-47B4-9F74-95761ECBA622

Q37624523-B8DF5373-2BAD-4E66-B0FE-0CE85CB0D6E3

Q37624523-CA4FAEE4-C74D-4253-8DDB-100451A4B8D0

Q37624523-CEC21C8F-A3E0-4897-B4E8-D36E43CA16A9

P2860

Q37624523-0CECE1FE-3F5E-497D-B7FD-01851DF4E643

Q37624523-14890CFF-956B-4255-A958-41AB723E56D4

Q37624523-46B5F7AC-DB94-43B0-85A8-FBF6F5CE0480

Q37624523-4AD2EC51-F558-45BB-9B7D-C5C437DEE82C

Q37624523-6545FE2A-5594-4B08-8C68-3C87251E6516

Q37624523-668C58EF-A316-4EAF-AA5F-EB9C3D1A7242

Q37624523-6E60604D-C9EF-496C-AE07-FBAFFAB7E13F

Q37624523-84D516D2-241B-488B-90A5-02C74B125F32

Q37624523-9235B2A0-4D0E-4A7F-A4DD-C3D3F2EB2CBB

Q37624523-9CFA5209-D5D7-4C7E-8E0F-A1E09A6B3289

P304

Q37624523-54EFBA3C-4DA9-4EA7-B530-D48CA34B0E9A

P31

Q37624523-989F9AAD-2C9D-4F0A-B869-6D89A474D816

P356

Q37624523-3B2187FE-AD45-4549-8BEB-06704368CA3A

P407

Q37624523-1D38053F-7D9B-4BC1-A917-3CD882DD0B9B

P433

Q37624523-D94DF0F4-A3C5-4961-BB5B-C67F1D899913

P478

Q37624523-60D0B78F-89AE-4420-A665-83B62372C1B2

P577

Q37624523-3B62BBC4-E7CB-4E19-B7AD-376E32D3117F

P698

Q37624523-5B1AB6D0-0CDF-4C2E-AEF9-0A254B3D4BCE

P921

Q37624523-2223B0D9-4CD2-4AA1-9B8F-6FAA416B4904

P932

Q37624523-4AA1F5AC-A237-47F0-A19B-DD1106E45B11

P356

P1433

World Journal of Gastroenterology

P1476

Long-term results of paclitaxe ...... ageal squamous cell carcinoma.

@en

P2093

Da-Shan Ai

http://www.w3.org/2001/XMLSchema#string

Guo-Liang Jiang

http://www.w3.org/2001/XMLSchema#string

Han-Ting Zhu

http://www.w3.org/2001/XMLSchema#string

Harun Badakhshi

http://www.w3.org/2001/XMLSchema#string

Hua-Rong Tang

http://www.w3.org/2001/XMLSchema#string

Jia-Ying Deng

http://www.w3.org/2001/XMLSchema#string

Jian-Hong Fan

http://www.w3.org/2001/XMLSchema#string

Jun-Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Kuai-Le Zhao

http://www.w3.org/2001/XMLSchema#string

Xiao-Mao Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials

Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.

Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.

Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis.

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma.

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113

Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer.

P304

540-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I3.540

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28210091

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5291860

http://www.w3.org/2001/XMLSchema#string